Can an online group program help Canadian veterans better manage migraine?

ISRCTN ISRCTN13638710
DOI https://doi.org/10.1186/ISRCTN13638710
Sponsor Université du Québec en Abitibi-Témiscamingue
Funders Université du Québec en Abitibi-Témiscamingue, Chronic Pain Centre of Excellence for Canadian Veterans
Submission date
08/03/2026
Registration date
12/03/2026
Last edited
10/03/2026
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Anaïs Lacasse
Principal investigator, Scientific, Public

445 Bd de l'Université
Rouyn-Noranda
J9X 5E4
Canada

Phone +1 (0) 819 762-0971 ext 2722
Email Anais.Lacasse@uqat.ca

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingOpen (masking not used)
ControlActive
AssignmentParallel
PurposeTreatment, Self management
Scientific titleImpact of an online group-based migraine self-management program for French-speaking Canadian veterans: a pragmatic randomized controlled trial
Study objectives
Ethics approval(s)

Approved 20/02/2026, Research Ethics Committee of the University of Quebec in Abitibi-Témiscamingue (CÉR-UQAT) (445 Bd de l'Université, Rouyn-Noranda, J9X 5E4, Canada; +1 (0)819 762 0971 ext 2113; CER@uqat.ca), ref: 2026-01_Ferland, Lise

Health condition(s) or problem(s) studiedMigraine
InterventionParticipants will be randomly assigned to the intervention or control group using a computer-generated randomization sequence created with the online randomization tool Randomizer.org. Participants will first be stratified by sex assigned at birth, and then randomly allocated to either the intervention group or the waitlist control group.

Experimental group (intervention):
Participants will take part in the Migraine Self-Management Program, delivered online in a group format via Zoom. The program consists of biweekly synchronous workshops facilitated by a qualified healthcare professional (physiotherapist and researcher). A manual (paper and PDF) is provided. Sessions include practical strategies for migraine self-management, education on triggers, coping techniques, and exercises. Attendance will be tracked, and reasons for drop-out will be documented. Participants will also record migraine episodes using a paper calendar or the Migraine Tracker app to support accurate outcome measurement.

Control group:
Participants on the waitlist will receive informational emails every 2 weeks covering the same topics as the program without the interactive sessions. After 6 months, they will have the option to participate in the full online program.
Intervention typeBehavioural
Primary outcome measure(s)
  1. Self efficacy measured using French-Canadian Chronic Pain Self-Efficacy Scale at 0, 3, 6, 9 and 12 months
Key secondary outcome measure(s)

1. Pain intensity and pain interference as well as broader health domains measured using PROMIS-29 Profile v2.0 at 0, 3, 6, 9 and 12 months
2. Functional impact of migraine on daily activities measured using the Headache Impact Test (HIT-6) at 0, 3, 6, 9 and 12 months
3. Migraine-specific quality of life measured using the Migraine-Specific Quality of Life Questionnaire (MSQ) at 0, 3, 6, 9 and 12 months
4. Participants’ perceived overall change in pain symptoms measured using the Patient Global Impression of Change (PGIC) at 3, 6, 9 and 12 months
5. Burden of migraine between headache episodes measured using the Migraine Interictal Burden Scale (MIBS-4) at 0, 3, 6, 9 and 12 months
6. Headache frequency: number of headache episodes recorded using a headache diary (paper calendar) or the Migraine Tracker application at 0, 3, 6, 9 and 12 months

Completion date30/06/2027

Eligibility

Participant type(s)
Age groupMixed
Lower age limit18 Years
Upper age limit100 Years
SexAll
Target sample size at registration40
Key inclusion criteria1. Canadian veterans living with migraine
2. Able to take part in a francophone online group
3. Consent to be part of the study
Key exclusion criteriaDoes not meet the inclusion criteria
Date of first enrolment10/03/2026
Date of final enrolment31/12/2026

Locations

Countries of recruitment

  • Canada

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
IPD sharing plan

Editorial Notes

10/03/2026: Study's existence confirmed by the Research Ethics Committee of the University of Quebec in Abitibi-Témiscamingue (CÉR-UQAT).